Can Fite Biofarma Ltd (CANF)

1.80
0.02 1.24
AMEX : Health Care
Prev Close 1.82
Open 1.76
Day Low/High 1.76 / 1.83
52 Wk Low/High 1.46 / 7.85
Volume 40.29K
Avg Volume 62.60K
Exchange AMEX
Shares Outstanding 16.35M
Market Cap 29.77M
EPS -0.50
P/E Ratio 7.28
Div & Yield N.A. (N.A)

Latest News

Can-Fite Concludes Successful Clinical Investigator Meeting For Its ACRobat Phase III Trial Of Piclidenoson In The Treatment Of Rheumatoid Arthritis

Piclidenoson is being developed as a first line therapy and replacement for the current standard of care, Methotrexate (MTX), the most widely used drug for rheumatoid arthritis

Can-Fite Establishes Clinical Advisory Board For NAFLD/NASH

- Board members are Key Opinion Leaders in the field of liver diseases

Can-Fite's Liver Protective Drug Namodenoson Enters Phase II Trial For Treatment Of NAFLD/NASH

- $35 Billion treatment market by 2025 with need for an FDA approved drug

New Preclinical Data Show Can-Fite's Namodenoson (CF102) Prevents Progression Of Liver Fibrosis

- Phase II trial to treat NAFLD/NASH expected to commence in 2017

Can-Fite Gears Up For ACRobat, Its Phase III Trial Of Piclidenoson In Rheumatoid Arthritis

-- Patient enrollment to commence Q2 2017

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BKD, CCE, CFBK, FIT Downgrades: FWRD, SIG, VIA Initiations: CANF Read on to get TheStreet Quant Ratings' detailed report:

Can-Fite BioPharma (CANF) Stock Jumps on Positive Pre-Clinical Data

Can-Fite BioPharma (CANF) Stock Jumps on Positive Pre-Clinical Data

Can-Fite BioPharma (CANF) stock is gaining on Monday afternoon as the company announced pre-clinical data for CF602, which demonstrated statistically significant full recovery from erectile dysfunction after a single dose.

Can-Fite BioPharma (CANF) Stock Tanks After Pricing Secondary Offering

Can-Fite BioPharma (CANF) Stock Tanks After Pricing Secondary Offering

Can-Fite BioPharma (CANF) shares are down over 10% after pricing its secondary registered direct offering of 1.1 million shares.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for under $10 a share look ready to break out and trade higher from current levels.

Can-Fite BioPharma (CANF) Stock Continues to Spike Following Fast Track Designation

Can-Fite BioPharma (CANF) Stock Continues to Spike Following Fast Track Designation

Can-Fite (CANF) shares are up after the company's liver cancer treatment candidate was granted fast track designation by the FDA.

Can-Fite BioPharma (CANF) Stock Spikes on Fast Track Designation

Can-Fite BioPharma (CANF) shares are up over 40% after its liver cancer treatment candidate received FDA fast track designation.

Can-Fite BioPharma (CANF) Stock Plummets to 52-Week Low Today on Psiorasis Drug Trial Results

Can-Fite BioPharma (CANF) Stock Plummets to 52-Week Low Today on Psiorasis Drug Trial Results

Shares of Can-Fite BioPharma (CANF) plunged to a one-year low on Monday announced that its drug candidate CF101 did not achieve its primary endpoint in a Phase II/III psoriasis trial.

3 Stocks Raising The Drugs Industry Higher

3 Stocks Raising The Drugs Industry Higher

TheStreet highlights 3 stocks that pushed the Drugs industry

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Advancing The Drugs Industry

3 Stocks Advancing The Drugs Industry

TheStreet highlights 3 stocks that pushed the Drugs industry

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.

3 Stocks Pushing The Health Care Sector Lower

3 Stocks Pushing The Health Care Sector Lower

TheStreet highlights 3 stocks pushing the Health Care sector lower today.

3 Stocks Pushing The Drugs Industry Lower

3 Stocks Pushing The Drugs Industry Lower

TheStreet highlights 3 stocks pushing the Drugs industry lower today.